Single-Blind, Multicenter, Placebo Controlled, Parallel Study to Assess the Safety and Efficacy of Intralesional Interferon α-2b for Minimally Invasive Treatment for Peyronie’s Disease
Hellstrom WJ, Kendirci M, Matern R, Cockerham Y, Myers L, Sikka SC, Venable D, Honig S, McCullough A, Hakim LS, Nehra A, Templeton LE, Pryor JL. Single-Blind, Multicenter, Placebo Controlled, Parallel Study to Assess the Safety and Efficacy of Intralesional Interferon α-2b for Minimally Invasive Treatment for Peyronie’s Disease. Journal Of Urology 2006, 176: 394-398. PMID: 16753449, DOI: 10.1016/s0022-5347(06)00517-9.Peer-Reviewed Original ResearchConceptsIntralesional interferon alpha-2bAlpha-2bInterferon alpha-2bPeyronie's diseasePenile curvatureInterferon alpha-2b therapyPlaque sizeAlpha-2b therapyIntralesional interferon αMean International IndexErectile Function scoreFlu-like symptomsBlood flow improvementParallel studyPenile painPlacebo-ControlledPain resolutionConsecutive patientsErectile functionFunction scoresMean ageControl armInternational IndexInvasive treatmentStudy completion